Year: 2021

CHARLOTTE, N.C., Nov. 24, 2021 (GLOBE NEWSWIRE) — Amergent Hospitality Group (OTCQB:AMHG) (“Amergent” or the “Company”), owner, operator and franchisor of multiple nationally-recognized restaurant brands, today provided the following corporate update covering its fiscal year 2021 third quarter performance Amergent Hospitality Group’s President, Fred Glick, stated, “Our third quarter 2021 performance was a continuation of momentum that has been building in recent quarters, highlights of which include increasing same store sales and integrating the recent acquisition of PizzaRev. We are pleased to report progress on virtually all fronts of our operations.” CEO Mike Pruitt continued, “We are pleased to again report positive income from operations. During the quarter, we successfully closed the acquisition...

NOT FOR DISTRIBUTION IN OR INTO THE UNITED STATES OF AMERICA, JAPAN, CANADA, SOUTH AFRICA or AUSTRALIA24 November 2021, 2:15pm, Antwerp, Belgium: VGP NV (‘VGP’ or ‘the Group’), a European provider of high-quality logistics and semi-industrial real estate, announces the following:VGP is launching a capital increase in cash by means of a private placement of new shares via an accelerated bookbuild offering to international institutional investors (the ‘Capital Increase’) VGP is seeking to raise gross proceeds in the Capital Increase of approximately € 300 million The accelerated bookbuild procedure will start immediately after publication of this press release VGP has requested that trading of VGP shares on the Euronext Brussels’ regulated market be suspended until the results of the Capital Increase are published in a press release,...

Philips Angio CTNovember 24, 2021Philips showcases world’s first spectral detector angio-CT solution at RSNA 2021 Solution combines breakthrough spectral detector CT imaging and real-time fluoroscopy in a flexible environment where all modalities are operated through Philips Image-Guided Therapy System – Azurion with FlexArm Philips’ Spectral detector CT imaging in the interventional suite brings valuable additional information in minimally-invasive procedures for areas such as oncology, stroke, and trauma careAmsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today unveiled its vision for interventional medicine by bringing its breakthrough spectral CT imaging technology into a hybrid Angio CT suite. By combining the company’s unique Spectral CT 7500 system and...

SATO Corporation, Stock exchange release, 24 November, 2021 at 3.00 pm SATO Corporation and the European Investment Bank (EIB) have agreed on a long-term loan of €80 million. The loan is without asset-based security and guaranteed by a subsidiary. The funding received from the EIB will support renovations that will improve the energy efficiency of SATO’s current rental housing stock in the Helsinki Metropolitan Area as well as in Turku and Tampere over the next few years. The renovation projects aim to improve the energy efficiency of properties that have reached the age for major renovations by at least 30%. In its Sustainability Programme, SATO is committed to curbing climate change and reducing greenhouse gas emissions, and the company is aiming to be carbon neutral by 2030 as regards carbon dioxide emissions from property energy usage....

TORONTO, Nov. 24, 2021 (GLOBE NEWSWIRE) — Petrolympic Ltd. (TSX.V:PCQ) (OTC:PCQRF) (the “Company”) is pleased to announce that the Company has entered into an agreement to acquire three (3) additional Mining Claims covering 75 Ha and located in the heart of the previously purchased Evangeline Lake gold property, which consists of 24 map designated mining claims (cells) covering 600 Ha Southwest of Espanola, Ontario, District of Sudbury (NTS 41/04F), approximately 70 km Southwest of the town of Sudbury, a major gold mining center in Central Ontario. On execution of the purchase agreement between the vendors and the company, the purchase price will be satisfied through the issuance of an aggregate of 200,000 common shares of the Company. Upon the completion of the transaction the Company will have acquired 100% interest...

NOT FOR DISTRIBUTION IN THE UNITED STATES OR TO U.S. NEWSWIRE SERVICES TORONTO, Nov. 24, 2021 (GLOBE NEWSWIRE) —  Omai Gold Mines Corp. (TSXV:OMG) (“Omai” or the “Company”) is pleased to announce a non-brokered private placement offering (the “Offering”) for aggregate gross proceeds of up to C$4,500,000 through the issuance of units of the Company (the “Units”) at a price of C$0.11 per Unit. Each Unit will consist of one common share (“Common Share”) and one-half of a common share purchase warrant. Two such half warrants constitute a full warrant (a “Warrant”). Each Warrant entitles the holder to acquire one Common Share at an exercise price of C$0.20 for a period of 24 months from the closing date of the Offering. Elaine Ellingham, Chief Executive Officer commented: “Our recently...

REDWOOD CITY, Calif., Nov. 24, 2021 (GLOBE NEWSWIRE) — Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage precision oncology company focused on developing targeted drugs to inhibit frontier targets that drive and sustain RAS-addicted cancers, today announced that the company will participate in the 4th Annual Evercore ISI HealthCONx Conference. Mark A. Goldsmith, M.D., Ph.D., chief executive officer and chairman of Revolution Medicines, will be the featured participant in a fireside chat at the event. Details of the company’s participation are as follows:4th Annual Evercore ISI HealthCONx ConferenceConference Date: November 30 – December 2, 2021Fireside Chat Time/Date: 11:45 a.m. Eastern on Thursday, December 2, 2021Format: Virtual conference; webcast available        To access the live webcast of the fireside chat,...

Adds to PharmaTher’s existing FDA orphan drug portfolio with amyotrophic lateral sclerosis and complex regional pain syndrome Strengthens commitment to treat rare disorders and life-threatening conditions with ketamineTORONTO, Nov. 24, 2021 (GLOBE NEWSWIRE) — PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a clinical-stage psychedelics biotech company, is pleased to announce that it has applied with the U.S. Food and Drug Administration (“FDA”) to receive Orphan Drug Designation (“ODD”) for ketamine to treat Status Epilepticus (“SE”), a rare neurological disorder requiring emergency treatment for a seizure. The Company has received FDA ODD for ketamine to treat amyotrophic lateral sclerosis (“ALS”) and complex regional pain syndrome (“CRPS”). The addition of SE strengthens the Company’s pharmaceutical...

Pilot program in Indonesia is on track with positive results and support for Achiko’s proprietary, low-cost rapid Covid-19 diagnostic test, AptameX, alongside its sister digital passporting service Teman Sehat (“Health Buddy”) Approval for the second-generation AptameX test kit expected in December from Indonesia’s Ministry of Health CE Mark registration is close to finalization with filing early next year Initial production of first-generation AptameX test kit is underway in Indonesia to fulfil prior sales orders and shipment early next weekZURICH, Switzerland, Nov. 24, 2021 (GLOBE NEWSWIRE) — Ad hoc announcement pursuant to Art. 53 LR –Achiko AG (SWX: ACHI, ISIN CH0522213468) (“Achiko”, the “Company”) is pleased to report substantial progress with the commercialization of both its rapid Covid-19 diagnostic test AptameX™ and...